Lung - nontumor
Varicella zoster pneumonia

Author: Elliot Weisenberg, M.D. (see Authors page)

Revised: 18 July 2018, last major update September 2011

Copyright: (c) 2003-2018,, Inc.

PubMed search: varicella zoster pneumonia

Cite this page: Weisenberg, E. Varicella zoster pneumonia. website. Accessed November 21st, 2018.
Clinical features
  • Overwhelmingly a benign disease in childhood (Eur J Clin Microbiol Infect Dis 2011;30:435)
  • Adults with infection have 25× risk of children in developing pneumonia; occurs in 10% - 15% of adult patients (Ann Thorac Med 2007;2:163)
  • Greatest risk of severe disease in immunosuppressed patients, especially bone marrow transplant recipients, patients with chronic lung disease, pregnant women and neonates
  • Incidence has declined with effective treatment, but is increasing due to unvaccinated individuals
  • Diagnosis usually apparent from skin lesions and clinical history, but immunohistochemistry, culture or PCR may be necessary to rule out HSV
  • Pneumonia usually occurs 2 - 7 days after rash appears
  • Pulmonary calcifications may occur after recovery
  • Untreated pneumonia has 10% - 40% mortality rate
Gross description
  • Heavy, firm and purple lungs
  • May have hemorrhagic lesions on pleura resembling skin lesions
Microscopic (histologic) description
  • Necrosis of bronchial and alveolar epithelium, acute inflammation and hemorrhage, eosinophilic nuclear inclusions and rare multinucleated cells at edge of necrotic foci